Compare INMB & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | SATL |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 482.3M |
| IPO Year | 2018 | N/A |
| Metric | INMB | SATL |
|---|---|---|
| Price | $1.16 | $5.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $5.87 | $5.50 |
| AVG Volume (30 Days) | 430.5K | ★ 7.7M |
| Earning Date | 05-07-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,000.00 | N/A |
| Revenue This Year | $264.29 | $68.54 |
| Revenue Next Year | N/A | $56.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $1.26 |
| 52 Week High | $11.64 | $6.84 |
| Indicator | INMB | SATL |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 70.80 |
| Support Level | N/A | $3.18 |
| Resistance Level | $1.48 | $5.93 |
| Average True Range (ATR) | 0.08 | 0.59 |
| MACD | -0.00 | 0.36 |
| Stochastic Oscillator | 4.69 | 73.01 |
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.